JUN and inflammatory bowel disease: IBD pathologies rapidly enhance the activation of JNK and its transcriptional effector substrate c-Jun in animals and humans, and link the JNK pathway with the initiation and development of intestinal or gastric inflammation including human IBD [9], [11], [12], [40], [56].